Worse response axSpA patients to second TNFi versus first TNFi Presented ByDr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal ConferenceEULAR 2020 14 August, 2020 10:27
AxSpA real-life remission rates higher on biologics Presented ByDr Charlotte Baert, Saint Luc University Hospital, Belgium ConferenceEULAR 2020 14 August, 2020 10:24
Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis Presented ByProf. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands TrialC-VIEW ConferenceEULAR 2020 14 August, 2020 10:19
